St Mary's Surgery - News

  • 16 Jul 2019

    D R U G A L E R T - Emerade 150mcg, 300mcg and 500mcg

    Bausch & Lomb UK limited has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle. This issue was first detected in June 2018 during routine stability testing of the syringe component of Emerade, with potential to affect 1.5 in every ten thousand pens, and therefore considered a rare event. However, recent information indicates that the potential occurrence of needle blockage in batches on the market is higher than first estimated and we are therefore bringing it to the attention of patients. The potential for units on the market to have a blockage of the needle which could lead to Emerade failing to deliver a dose when activated is now estimated to be 0.23 %*, which would affect 2.3 in every thousand pens. However, if the patient follows the existing advice to carry EL (19)A/17 Page 2 of 3 two in-date pens with them at all times, the risk of not being able to deliver a dose of adrenaline before the emergency services arrive is substantially reduced (from 0.23% to 0.000529%).

    Read More »
  • 1 Jul 2019
  • 28 Jun 2019

    Patient Alert - Medication RECALL three products that are being recalled to patient level are Clexane 8000iu Injection 0.8ml; Neupro 4mg/24 hr patches; and Vimpat 100mg tablets.

    It has recently come to our attention that medicines have been taken out of the regulated medicines’ supply chain during distribution and later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period and, while unlikely, could impact their effectiveness. The products have been parallel imported into the UK by B & S Healthcare from Italy and have been re-labelled in B & S Healthcare livery. The same batches of products may have been parallel imported legitimately into the UK by other importers. Only those packs in B & S Healthcare livery are within the scope of this Alert. The products are believed to be legitimate. There is no evidence that they have been tampered with and these medicines are stable at room temperature.

    Read More »
  • 17 Jun 2019

    Disopyramide 150/200mg supply alert

    Disopyramide 150MG-200MG SUPPLY ISSUE.pdf

    Read More »
  • 13 Jun 2019

    RECALL - Paracetamol 500 capsules

    M & A Pharmachem is recalling the above batches because a small number of pots from each batch have been found to contain discoloured tablets due to fungal contamination. The fungi have been identified as Penicillium citrinium and Penicillium brevicompactum. It is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

    Read More »
  • 6 Jun 2019

    Epanutin® (phenytoin) 30mg/5ml Oral Suspension – Supply Disruption

    Epanutin® (phenytoin) 30mg/5ml oral suspension will be out of stock from w/c 10th June for 6-8 weeks.

    Read More »
  • 5 Jun 2019

    Change to apprerance of Sinemet tablets

    Merck Sharp & Dohme Limited (MSD) are still experiencing intermittent supply issues which are expected to continue until early June with the following products: • Sinemet 25mg/250mg 10×10 tablets. • Sinemet 12.5mg/50mg 9×10 tablets. • Sinemet CR 50mg/200mg 6×10 tablets. • Sinemet plus 10mg/100mg 10×10 tablets. MSD have confirmed the following Sinemet products should now be available: • Sinemet Plus 25mg/100mg 10×10 tablets. • Sinemet Half CR 25mg/100mg 6×10 tablets. Change of appearance With a view to providing a more consistent supply MSD have moved manufacturing of 3 Sinemet products to another manufacturing site. This move means that the appearance of 3 Sinemet products will change from round to oval. The 3 products that will change their appearance from early May are: • Sinemet 10mg/100mg tablets • Sinemet 25mg/250mg tablets • Sinemet Plus 25mg/100mg tablets

    Read More »
  • 15 May 2019

    Hospitalisation and deaths linked to consumption of 2,4-dinitrophenol (DNP): rapid

    DNP is a toxic industrial chemical that is unfit for human consumption and illegal for use in foodstuffs. Despite best efforts to remove DNP-containing products from sale, they are still available and may be used by people trying to alter their appearance, such as body builders and those attempting to achieve rapid or extreme weight loss, including some who are vulnerable.

    Read More »
  • 29 Apr 2019

    Prednisolone 5mg Tablets - error on the Braille for certain batches, which means that the strength reads as 1mg instead of 5mg

    Prednisolone 5mg Tablets - error on the Braille for certain batches, which means that the strength reads as 1mg instead of 5mg

    Read More »
  • 26 Apr 2019

    Walsall Pharmacy opening hours May bank holidays 2019

    Walsall Pharmacy opening hours May bank holidays 2019

    Read More »
« 1 2 3 4 5 » 
Your Neighbourhood Professionals. Just a Click Away!
Your Neighbourhood Professionals. Just a Click Away!